Oral anticoagulants and outcomes in adults ≥80 years with atrial fibrillation: A global federated health network analysis

Oral Anticoagulants in Extremely High Risk Very Elderly (>90 years) Patients with Atrial Fibrillation

(2021) Tze-Fan Chao et al.   HEART RHYTHM

Prescribing of direct oral anticoagulants and warfarin to older people with atrial fibrillation in UK general practice: a cohort study

(2021) Anneka Mitchell et al.   BMC Medicine

Oral anticoagulation improves survival in very elderly Chinese patients with atrial fibrillation: A report from the Optimal Thromboprophylaxis in Elderly Chinese Patients with Atrial Fibrillation (ChiOTEAF) registry

(2021) Yutao Guo et al.   International Journal of Stroke

Comparing Warfarin and 4 Direct Oral Anticoagulants for the Risk of Dementia in Patients With Atrial Fibrillation

(2021) So-Ryoung Lee et al.   STROKE

Oral Anticoagulants in the Oldest Old with Recent Stroke and Atrial Fibrillation

(2021) Alexandros A. Polymeris et al.   ANNALS OF NEUROLOGY

2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS)

(2020) Gerhard Hindricks et al.   EUROPEAN HEART JOURNAL

Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation

(2020) Ken Okumura et al.   NEW ENGLAND JOURNAL OF MEDICINE

2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

(2019) Craig T. January et al.   CIRCULATION

Identifying dementia cases with routinely collected health data: A systematic review

(2018) Tim Wilkinson et al.   Alzheimers & Dementia

Improving recruitment of older people to clinical trials: use of the cohort multiple randomised controlled trial design

(2015) A. Clegg et al.   AGE AND AGEING

Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials

(2013) Christian T Ruff et al.   LANCET